KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Preferred Stock Liabilities (2020 - 2023)

Historic Preferred Stock Liabilities for LifeMD (LFMD) over the last 4 years, with Q2 2023 value amounting to $5.0 million.

  • LifeMD's Preferred Stock Liabilities rose 1606.1% to $5.0 million in Q2 2023 from the same period last year, while for Jun 2023 it was $5.0 million, marking a year-over-year increase of 1606.1%. This contributed to the annual value of $4.6 million for FY2022, which is 1106.83% up from last year.
  • LifeMD's Preferred Stock Liabilities amounted to $5.0 million in Q2 2023, which was up 1606.1% from $4.7 million recorded in Q1 2023.
  • Over the past 5 years, LifeMD's Preferred Stock Liabilities peaked at $5.0 million during Q2 2023, and registered a low of $3.7 million during Q4 2020.
  • Its 4-year average for Preferred Stock Liabilities is $4.2 million, with a median of $4.2 million in 2022.
  • Over the last 5 years, LifeMD's Preferred Stock Liabilities had its largest YoY gain of 1606.1% in 2023, and its largest YoY loss of 1077.43% in 2023.
  • Quarter analysis of 4 years shows LifeMD's Preferred Stock Liabilities stood at $3.7 million in 2020, then grew by 12.45% to $4.1 million in 2021, then grew by 11.07% to $4.6 million in 2022, then rose by 10.23% to $5.0 million in 2023.
  • Its Preferred Stock Liabilities was $5.0 million in Q2 2023, compared to $4.7 million in Q1 2023 and $4.6 million in Q4 2022.